Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial

Clinical trial NCT06792214 · RECRUITING

Trial details

NCT number: NCT06792214
Sponsor: Mount Sinai Hospital, Canada
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

SARS CoV-2 Post-Acute Sequelae

Start date: 2025-01-03
Primary completion: 2026-01-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.